PROCEPT BioRobotics Balance Sheet Health
Financial Health criteria checks 5/6
PROCEPT BioRobotics has a total shareholder equity of $241.2M and total debt of $53.4M, which brings its debt-to-equity ratio to 22.2%. Its total assets and total liabilities are $374.1M and $132.9M respectively.
Key information
22.2%
Debt to equity ratio
US$53.44m
Debt
| Interest coverage ratio | n/a |
| Cash | US$196.76m |
| Equity | US$241.22m |
| Total liabilities | US$132.92m |
| Total assets | US$374.14m |
Recent financial health updates
Recent updates
Earnings Update: Here's Why Analysts Just Lifted Their PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Price Target To US$102
Oct 31
Procept BioRobotics: New Hydros Aquablation System To Fuel Next Leg Of Growth
Sep 12Procept BioRobotics: Risk Capital Unlock With FDA Hydros Approval
Aug 27Investors Appear Satisfied With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Prospects As Shares Rocket 28%
Aug 25Here's What Analysts Are Forecasting For PROCEPT BioRobotics Corporation (NASDAQ:PRCT) After Its Second-Quarter Results
Aug 04PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) P/S Is Still On The Mark Following 37% Share Price Bounce
May 21The Price Is Right For PROCEPT BioRobotics Corporation (NASDAQ:PRCT)
Apr 05US$56.67 - That's What Analysts Think PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Is Worth After These Results
Mar 01Despite Lacking Profits PROCEPT BioRobotics (NASDAQ:PRCT) Seems To Be On Top Of Its Debt
Feb 07Market Participants Recognise PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Revenues Pushing Shares 26% Higher
Dec 14Is There An Opportunity With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) 43% Undervaluation?
Feb 27Procept Biorobotics announces $52M debt refinancing
Oct 10Providence announces national contract for PROCEPT Biorobotics Aquabeam Systems
Sep 19Procept BioRobotics Has Resources To Ramp Up Commercialization
Sep 01Procept: Leveraging A Novel Water-Based System For Enlarged Prostate Treatment
May 26Need To Know: Analysts Are Much More Bullish On PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Revenues
May 10Financial Position Analysis
Short Term Liabilities: PRCT's short term assets ($323.0M) exceed its short term liabilities ($53.6M).
Long Term Liabilities: PRCT's short term assets ($323.0M) exceed its long term liabilities ($79.3M).
Debt to Equity History and Analysis
Debt Level: PRCT has more cash than its total debt.
Reducing Debt: Insufficient data to determine if PRCT's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PRCT has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: PRCT has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 24.4% each year.